Stay updated on LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial page.

Latest updates to the LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the prior funding/operating-status notice (Revision: v3.4.1).SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operating status with links to cc.nih.gov and opm.gov. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and updated metadata labels to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Capitalization and wording for FEAR Act data were adjusted, and older phrasing such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' was removed.SummaryDifference0.2%

- Check64 days agoChange DetectedAdded a Locations section listing multiple sites across China (Beijing Municipality, Guangdong, Henan, Hubei, Hunan, Jiangsu, Jilin, Liaoning, Nanjing, Shanghai Municipality, Sichuan, Yunnan).SummaryDifference1%

- Check71 days agoChange DetectedRemoved 'Type 1 diabetes' and the related topic 'MedlinePlus Genetics' from the page's related topics.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page now lists 'Type 1 diabetes' as a related topic and includes a related topic to MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial page.